EMEA-002209-PIP01-17-M03
Key facts
| Invented name |
Imcivree
|
| Active substance |
Setmelanotide
|
| Therapeutic area |
Nutrition
|
| Decision number |
P/0348/2022
|
| PIP number |
EMEA-002209-PIP01-17-M03
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Treatment of appetite and general nutrition disorders
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Rhythm Pharmaceuticals, Inc
Tel. +1 8572544457 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|